David Ledbetter is chief clinical officer of Dascena, a personalized medicine company.
David Ledbetter
Chief clinical officer
Dascena
From this contributor
There are no autism-specific genes, just brain genes
There is not yet a single example of a gene that, when mutated, increases the likelihood of autism but not of other neurodevelopmental conditions, including intellectual disability.
There are no autism-specific genes, just brain genes
By
David Ledbetter, Scott Myers
23 March 2021 | 5 min read
Developmental disorders should be viewed as continuum
Intellectual disability, autism, epilepsy and schizophrenia should be considered part of a spectrum of developmental brain dysfunction, says David Ledbetter.
Developmental disorders should be viewed as continuum
By
David Ledbetter
6 May 2013 | 3 min read
Explore more from The Transmitter
Neuro’s ark: Spying on the secret sensory world of ticks
Carola Städele, a self-proclaimed “tick magnet,” studies the arachnids’ sensory neurobiology—in other words, how these tiny parasites zero in on their next meal.
Neuro’s ark: Spying on the secret sensory world of ticks
Carola Städele, a self-proclaimed “tick magnet,” studies the arachnids’ sensory neurobiology—in other words, how these tiny parasites zero in on their next meal.
By
Calli McMurray
3 March 2026 | 6 min read
Autism in old age, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 2 March.
Autism in old age, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 2 March.
By
Jill Adams
3 March 2026 | 1 min read
Lack of reviewers threatens robustness of neuroscience literature
Simple math suggests that small groups of scientists can significantly bias peer review.
Lack of reviewers threatens robustness of neuroscience literature
Simple math suggests that small groups of scientists can significantly bias peer review.
By
Jakob Voigts
2 March 2026 | 14 min read